Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2001-06-26 / Proc. Natl. Acad. Sci. U.S.A. 2001 Jul;98(15):8809-14The use of dendritic cells in cancer therapy
/in Dendritic Cells, International Publications /von 2001-06-01 / Lancet Oncol. 2001 Jun;2(6):343-53Dendritic cells for specific cancer immunotherapy
/in Dendritic Cells, International Publications /von 2001-04-01 / Biol. Chem. 2001 Apr;382(4):507-20Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
/in Dendritic Cells, Glioblastoma, International Publications /von 2001-02-01 / Cancer Res. 2001 Feb;61(3):842-7In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-6Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
/in Dendritic Cells, Glioblastoma, International Publications /von 2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e8Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
/in Breast Cancer, Dendritic Cells, International Publications, Ovarian Cancer /von 2000-11-01 / Blood 2000 Nov;96(9):3102-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de